LONDON, UK – January 21, 2022 – Eternal Bioworks Corp. (“ETERNAL” or the “Company”), a leading biotech company dedicated to advancing the intersection of technology and biology to address some of the most critical challenges facing our planet, amidst the excitement of shipping its initial orders of Mycofood™, previously known as Kernel Mycofood Corp, has unveiled its new name, ETERNAL. This change reflects the company’s expanded ambition to become a leading platform for technology and innovation. Utilizing robotics, artificial intelligence, and other advanced technologies, ETERNAL aims to support life science research and address some of the most pressing challenges of our time.
As ETERNAL celebrates the market readiness of its flagship product, Mycofood™, the company also highlighted its ongoing expansion into other research areas, including space exploration technology and sustainable construction materials.
Following a recent corporate investment round, ETERNAL has seen its R&D valuation soar to over $42 million, with a company valuation that far exceeds this figure. This infusion of capital is set to propel the company’s future growth and development.
Despite the rebranding, the product name Mycofood™ will remain as a complete food solution, boasting exceptional health and nutritional benefits.
About Eternal Bioworks Corp.
Eternal Bioworks Corp. is at the forefront of biotechnological innovation, dedicated to advancing the intersection of technology and biology to address some of the most critical challenges facing our planet. Founded with the vision to revolutionize food systems and material production, Eternal leverages cutting-edge advancements in artificial intelligence, robotics, and bioprocessing to create sustainable solutions that are not only viable but vital for the future.
For more information, please contact us at [email protected]
